Search

VIRIDIAN THERAPEUTICS INC

Geschlossen

BrancheGesundheitswesen

23.59 4.94

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

22.39

Max

23.59

Schlüsselkennzahlen

By Trading Economics

Einkommen

15M

-105M

Verkäufe

9K

141K

EPS

-0.9

Gewinnspanne

-74,397.872

Angestellte

252

EBITDA

13M

-101M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+50.64% upside

Dividenden

By Acuity

Nächstes Ergebnis

4. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

683M

2.1B

Vorheriger Eröffnungskurs

18.65

Vorheriger Schlusskurs

23.59

Nachrichtenstimmung

By Acuity

21%

79%

44 / 340 Ranking in Healthcare

VIRIDIAN THERAPEUTICS INC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Aug. 2026, 20:05 UTC

Correlated Moves
News

Viridian Therapeutics shares rise after Truist Securities raised its price target to $39. The ARK Genomic Revolution ETF's gains may also influence the stock.

6. Aug. 2026, 21:02 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, extending five consecutive sessions of gains amid broader market resilience and positive economic data.

5. Aug. 2026, 23:02 UTC

Viridian Therapeutics Inc shares declined in after-market trading, sharply lower since Wednesday's close, despite finishing higher in the previous three sessions.

4. Aug. 2026, 21:02 UTC

Viridian Therapeutics shares are lower in after-hours trading, declining from earlier session highs despite being above the 20-day moving average.

3. Aug. 2026, 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reaching their lowest point despite a prior period of stability. No specific news was identified.

31. Juli 2026, 20:02 UTC

Viridian Therapeutics Inc's shares are lower today, breaking a trend of higher closes. Broader market factors, including rising Treasury yields, may be influencing this shift.

30. Juli 2026, 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, following earlier stability. Broader market uncertainty over the Federal Reserve's rate decision persists.

29. Juli 2026, 23:56 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Broader market uncertainty persists.

28. Juli 2026, 21:02 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reversing an initial uptick amid cautious broader market sentiment and declines in technology shares.

27. Juli 2026, 19:26 UTC

Viridian Therapeutics Inc is trading higher, maintaining strength since Friday's close and reflecting positive momentum near the upper end of its one-month trading range.

24. Juli 2026, 17:36 UTC

Viridian Therapeutics shares are higher since Thursday's close, recovering from earlier lows. Broader market sentiment improved amid declining crude oil prices.

22. Juli 2026, 19:26 UTC

Viridian Therapeutics Inc is trading higher during Wednesday's session, recovering from earlier lows despite the broader market's mixed performance.

21. Juli 2026, 19:51 UTC

Correlated Moves

Viridian Therapeutics Inc shares are trading higher, reflecting strong intraday performance. The move aligns with positive sentiment in the biotechnology sector.

20. Juli 2026, 19:01 UTC

Viridian Therapeutics Inc is advancing in Monday's session, despite earlier pullback. No specific company news was identified to explain the price movement.

Peer-Vergleich

Kursveränderung

VIRIDIAN THERAPEUTICS INC Prognose

Kursziel

By TipRanks

50.64% Vorteil

12-Monats-Prognose

Durchschnitt 33.91 USD  50.64%

Hoch 41 USD

Tief 22 USD

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für VIRIDIAN THERAPEUTICS INC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

13 ratings

13

Buy

0

Halten

0

Sell

Stimmung

By Acuity

44 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Durchschnitt

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

help-icon Live chat